This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Allan H. Ropper, MD

Arch Neurol. 1985;42(12):1194-1195.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

There are several lively controversies regarding intracranial pressure (ICP) in acute neurologic practice, including its meaning in cerebral hemorrhage, ischemic brain edema, Reye's syndrome, global anoxia, and viral encephalitis. The value of measuring ICP, different methods of treatment, and the benefits of aggressive therapy each have supporters and detractors. Many subsidiary questions also beg answers, such as how to select patients for monitoring, treatment tailored to the patient's measured ICP as opposed to blind therapy with mannitol and hyperventilation, the place of high-dose barbiturate therapy or craniectomy in patients who have failed medical therapy, and the use of steroids.

What is the neurologist, hampered by generations of passivity in therapeutics, to do? Monitor ICP or not? In my opinion, when this important problem is considered as a sequence of clinical problems, the answer is a compelling yes. My conclusions, based on personal experience and a biased reading of the . . . [Full Text PDF of this Article]

Author Affiliations
From the Department of Neurology, Neurological/Neurosurgical Intensive Care Unit, Massachusetts General Hospital, Boston.

Footnotes
Accepted for publication May 10, 1985.

Reprints not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?